Giant Cell Arteritis and Polymyalgia Rheumatica: Two Different but Often Overlapping Conditions

Seminars in Arthritis and Rheumatism

Volumn 33, Issue 5, 2004, Pages 289-293

  Gonzalez Gay, Miguel A ^a  

^a HOSPITAL XERAL CALDE   (Spain)

Author keywords

Elderly; Giant cell arteritis; Immunogenetic studies; Inflammatory response; Isolated polymyalgia rheumatica

Indexed keywords

CORTICOSTEROID; GENE PRODUCT; HLA DR ANTIGEN; INTERLEUKIN 6; LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA;

AGE; ALLELISM; BLOOD VESSEL BIOPSY; CLINICAL FEATURE; COMORBIDITY; CYTOKINE PRODUCTION; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; GIANT CELL ARTERITIS; HUMAN; INFLAMMATION; LABORATORY DIAGNOSIS; PHENOTYPE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; RHEUMATIC POLYMYALGIA; TEMPORAL ARTERY;

EID: 1942423162     PISSN: 00490172     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2003.09.007     Document Type: Editorial

References (41)

1. Salvarani C, Cantini F, Boiardi L, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med 2002; 347:261-71.
2. Gonzalez-Gay MA, Garcia-Porrua C. Epidemiology of the vasculitides. Rheum Dis Clin North Am 2001;27:729-49.
3. Salvarani C, Gabriel SE, O'Fallon WM, Hunder GG. The incidence of giant cell arteritis in Olmsted County, Minnesota: Apparent fluctuations in a cyclic pattern. Ann Intern Med 1995;123:192-4.
4. Caselli RJ, Hunder GG. Neurologic aspects of giant cell (temporal) arteritis. Rheum Dis Clin North Am 1993;19:941-53.
5. Gonzalez-Gay MA, Garcia-Porrua C, Llorca J, Hajeer AH, Branas F, Dababneh A, et al. Visual manifestations of giant cell arteritis. Trends and clinical spectrum in 161 patients. Medicine (Baltimore) 2000;79:283-92.
6. Evans JM, Hunder GG. Polymyalgia rheumatica and giant cell arteritis. Rheum Dis Clin North Am 2000;26:493-515.
7. Chuang TY, Hunder GG, Ilstrup DM, Kurland LT. Polymyalgia rheumatica: A 10-year epidemiologic and clinical study. Ann Intern Med 1982;97:672-80.
8. Healey LA. The relation of giant cell arteritis to polymyalgia rheumatica. Baillieres Clin Rheumatol 1991;5:371-8.
9. Gonzalez-Gay MA, Blanco R, Sanchez-Andrade A, Vazquez-Caruncho M. Giant cell arteritis in Lugo, Spain: A more frequent disease with fewer classic features. J Rheumatol 1997;24:2166-70.
10. Rynes RI, Mika P, Bartholomew LE. Development of giant cell (temporal) arteritis in a patient "adequately" treated for polymyalgia rheumatica. Ann Rheum Dis 1977;36:88-90.
11. Papadakis MA, Schwartz MD. Temporal arteritis after normalization of erythrocyte sedimentation rate. Arch Intern Med 1986;146:2283-4.
12. Smith CA, Fidler WJ, Pinals RS. The epidemiology of giant cell arteritis. Report of a ten-year study in Shelby County, Tennessee. Arthritis Rheum 1983;26:1214-9.
13. Salvarani C, Gabriel SE, O'Fallon WM, Hunder GG. Epidemiology of polymyalgia rheumatica in Olmsted County, Minnesota, 1970-1991. Arthritis Rheum 1995;38:369-73.
14. Healey LA. The spectrum of polymyalgia rheumatica. Clin Geriatr Med 1988;4:323-31.
15. Weyand CM, Hicok KC, Hunder GG, Goronzy G. The HLA-DRB1 locus as a genetic component in giant cell arteritis. J Clin Invest 1992;90:2355-61.
16. Weyand CM, Hunder NNH, Hicok KC, Hunder GG, Goronzy G. HLA-DRB1 alleles in polymyalgia rheumatica, giant cell arteritis, and rheumatoid arthritis. Arthritis Rheum 1994;37:514-20.
17. Cantini F, Niccoli L, Storri L, Nannini C, Olivieri I, Padula A, et al. Are polymyalgia rheumatica and giant cell arteritis the same disease? Semin Arthritis Rheum 2004;33:294-301.
18. Gonzalez-Gay MA, Garcia-Porrua C. Systemic vasculitis in adults in northwestern Spain, 1988-1997. Clinical and epidemiologic aspects. Medicine (Baltimore) 1999;78:292-308.
19. Gonzalez-Gay MA, Garcia-Porrua C, Rivas MJ, Rodriguez-Ledo P, Llorca J. Epidemiology of biopsy proven giant cell arteritis in northwestern Spain: Trend over an 18 year period. Ann Rheum Dis 2001;60:367-71.
20. Gonzalez-Gay MA, Garcia-Porrua C, Vazquez-Caruncho M, Dababneh A, Hajeer A, Ollier WE. The spectrum of polymyalgia rheumatica in northwestern Spain: Incidence and analysis of variables associated with relapse in a 10 year study. J Rheumatol 1999;26:1326-32.
21. Gonzalez-Gay MA, Garcia-Porrua C, Salvarani C, Hunder GG. Diagnostic approach in a patient presenting with polymyalgia. Clin Exp Rheumatol 1999;17:276-8.
22. Gonzalez-Gay MA, Garcia-Porrua C, Salvarani C, Olivieri I, Hunder GG. The spectrum of conditions mimicking polymyalgia rheumatica in Northwestern Spain. J Rheumatol 2000;27:2179-84.
23. Arnet FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1990;33:1101-7.
24. Gonzalez-Gay MA, Garcia-Porrua C, Vazquez-Caruncho M. Polymyalgia rheumatica in biopsy proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica. J Rheumatol 1998;25:1750-5.
25. Gonzalez-Gay MA, Santiago J, Monte R, Blanco R. Low-dose corticosteroids and blindness in giant cell arteritis. Br J Rheumatol 1996;35:702-3.
26. Gonzalez-Gay MA, Blanco R, Rodriguez-Valverde V, Martinez-Taboada VM, Delgado-Rodriguez M, Figueroa M, et al. Permanent visual loss and cerebrovascular accidents in giant cell arteritis: Predictors and response to treatment. Arthritis Rheum 1998;41:1497-504.
27. Uddhammar A, Eriksson AL, Nystrom L, Stenling R, Rantapaa-Dahlqvist S. Increased mortality due to cardiovascular disease in patients with giant cell arteritis in northern Sweden. J Rheumatol 2002;29:737-42.
28. Evans JM, O'Fallon WM, Hunder GG. Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis. A population-based study. Ann Intern Med 1995;122: 502-7.
29. Gonzalez-Gay MA, Amoli MM, Garcia-Porrua C, Ollier WE. Genetic markers of disease susceptibility and severity in giant cell arteritis and polymyalgia rheumatica. Semin Arthritis Rheum 2003;33:38-48.
30. Jacobsen S, Baslund B, Madsen HO, Tvede N, Svejgaard A, Garred P. Mannose-binding, lectin variant alleles and HLA-DRB1*04 alleles are associated with giant cell arteritis. J Rheumatol 2002 2002;29:2148-53.
31. Bignon JD, Barrier J, Soulillou JP, Martin P, Grolleau JY. HLA-DR4 in giant cell arteritis. Tissue Antigens 1984;24: 60-2.
32. Combe B, Sany J, Le Quellec A, Clot J, Eliaou JF. Distribution of HLA-DRB1 alleles of patients with polymyalgia rheumatica and giant cell arteritis in a Mediterranean population. J Rheumatol 1998;25:94-8.
33. Rauzy O, Fort M, Nourhashemi F, Alric L, Juchet H, Ecoiffier M, et al. Relation between HLA DRB1 alleles and corticosteroid resistance in giant cell arteritis. Ann Rheum Dis 2000;59:574-5.
34. Dababneh A, Gonzalez-Gay MA, Garcia-Porrua C, Hajeer A, Thomson W, Ollier W. Giant cell arteritis and polymyalgia rheumatica can be differentiated by distinct patterns of HLA class II association. J Rheumatol 1998;25:2140-5.
35. Labbe P, Flipo RM, Fajardy I, Hachulla E, Houvenagel E, Hatron PY, et al. HLA DRB1 polymorphism in rhizomelic pseudo-polyarthritis and Horton disease. Rev Med Interne 1995;16:778-81.
36. Roche NE, Fulbright JW, Wagner AD, Hunder GG, Goronzy JJ, Weyand CM. Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis. Arthritis Rheum 1993;36:1286-94.
37. Uddhammar A, Sundqvist KG, Ellis B, Rantapaa-Dahlqvist S. Cytokines and adhesion molecules in patients with polymyalgia rheumatica. Br J Rheumatol 1998;37:766-9.
38. Mattey DL, Hajeer AH, Dababneh A, Thomson W, Gonzalez-Gay MA, Garcia-Porrua C, et al. Association of giant cell arteritis and polymyalgia rheumatica with different tumor necrosis factor microsatellite polymorphisms. Arthritis Rheum 2000;43:1749-55.
39. Dasgupta B, Panayi GS. Interleukin-6 in serum of patients with polymyalgia rheumatica and giant cell arteritis. Br J Rheumatol 1990;29:456-8.
40. Weyand CM, Fulbright JW, Hunder GG, Evans JM, Goronzy JJ. Treatment of giant cell arteritis: Interleukin-6 as a biologic marker of disease activity. Arthritis Rheum 2000;43: 1041-8.
41. Gonzalez-Gay MA, Hajeer AH, Dababneh A, Garcia-Porrua C, Mattey DL, Amoli MM, et al. IL-6 promoter polymorphism at position -174 modulates the phenotypic expression of polymyalgia rheumatica in biopsy-proven giant cell arteritis. Clin Exp Rheumatol 2002;20:179-84.